Used primarily in peptide synthesis as a protected amino acid building block, this compound enables the introduction of a terminal alkyne functionality into peptide chains. The alkyne group allows for further modification via click chemistry, particularly copper-catalyzed azide-alkyne cycloaddition (CuAAC), which is valuable in bioconjugation, labeling, and developing peptide-based pharmaceuticals. The Fmoc group ensures compatibility with solid-phase synthesis by providing orthogonal protection that can be removed under mild basic conditions, preserving other functional groups in the molecule. Its structure supports the synthesis of modified peptides for research in drug discovery and chemical biology.